<DOC>
	<DOCNO>NCT01002339</DOCNO>
	<brief_summary>New onset diabetes renal transplantation ( NODAT ) common severe complication negatively influence graft patient survival . Cyclosporine ( CsA ) Tacrolimus basis modern immunosuppression . Tacrolimus superior CsA term acute rejection graft function . However , Tacrolimus increase 2 time risk NODAT compare CsA .</brief_summary>
	<brief_title>Optimum Immunosuppression Renal Transplant Recipients.New Onset Diabetes After Transplantation</brief_title>
	<detailed_description>New onset diabetes renal transplantation ( NODAT ) common severe complication negatively influence graft patient survival . CsA Tacrolimus basis modern immunosuppression . Tacrolimus superior CsA term acute rejection graft function . However , increase 2 time risk NODAT compare CsA . Objectives : ) To compare incidence NODAT glucose intolerance 3 different regime : Tacrolimus rapid steroid withdrawal ; Tacrolimus steroids minimization ; CsA steroid minimization ; b ) To compare acute rejection rate , renal function graft patient survival different regime ; c ) investigate influence different regime subclinical atheromatosis . A total 210 patient randomize . The primary efficacy variable NODAT glucose intolerance 1 year ; secondary efficacy variable acute rejection , renal function , change carotid intima-media thickness time .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Basiliximab</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>Primary renal transplant recipient end stage renal disease No prior history diabetes mellitus transplant Absence Immunologic risk define investigator criterion ( Panel Reactive Antibody ) PRA &lt; 50 % Absence severe infection hepatitis C B infection Efficient contraception woman study Additionally must meet one `` Metabolic Criteria Recipient age &gt; =60 Recipient age 45 59 year least one follow metabolic criterion : Prior transplantation Triglycerides ( TGS ) &gt; 200mg/dl combination body mass index ( BMI ) &gt; 27 Triglycerides &gt; 150 mg/dl combination HDLcholesterol &lt; 40 mg/dl men &lt; 50 mg/dl woman Triglycerides &gt; 150 mg/dl . Patients type I II diabetes prior transplantation define American Diabetes Association ( ADA ) criteria Recipient age 45 Patients receive second renal transplant Patients high immunological risk PRA ( panel reactive antibody level ) &gt; =50 % Severe infection hepatitis C B infection . Dual renal transplant double transplant organ .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>